#JustPublished!
Autumn #vaccination campaigns focused on older age groups and other high-risk populations are key to decrease impact of #COVID19.
Read full report: http://bit.ly/3ZJgEWk
Press release: http://bit.ly/3MdQjwJ
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591895912792069
To decrease the impact of #COVID19 hospitalisations and mortality, countries should plan for a continued roll-out of #COVID19vaccines.
Efforts should focus on protecting older adults & other vulnerable groups, such as those with underlying comorbidities & the immunocompromised.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591898941083648
According to #ECDC surveillance data, with every new wave of #COVID19 infection, individuals in older age groups are more likely to be hospitalised.
Data suggests persisting #SARSCoV2 transmission in EU/EEA & therefore, a continuous risk of severe disease for vulnerable groups.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591902204182528
Mathematical models detailed in the report show that an autumn 2023 vaccination programme with very high vaccine uptake targeting individuals 60+ is expected to prevent up to 32% of #COVID19-related hospitalizations across the EU/EEA.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591905198874627
Assuming a very high vaccine uptake, combining an autumn 2023 vaccination programme for 60+ with a spring 2023 vaccination campaign for 80+ is expected to prevent up to 44% of #COVID19-related hospitalizations.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591908076187649
In conducting the mathematical modelling, #ECDC experts took into consideration the knowledge gathered on a number of factors including waning vaccine effectiveness, age groups targeted by the recent autumn/winter 2022/23 vaccine booster campaign & 2022 epidemiological situation.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591910575972352
#PublicHealth authorities may consider developing targeted communication focused on reaching high-priority groups through trusted channels, providing clear information on groups recommended for vaccination, the type of vaccines available & timing.
More: http://bit.ly/3MdQjwJ
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1643591916020178948